{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T03:46:54Z","timestamp":1791604014264,"version":"4.3.4"},"reference-count":228,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/M006727\/1"],"award-info":[{"award-number":["BB\/M006727\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronological age represents the greatest risk factor for many life-threatening diseases, including neurodegeneration, cancer, and cardiovascular disease; ageing also increases susceptibility to infectious disease. Current efforts to tackle individual diseases may have little impact on the overall healthspan of older individuals, who would still be vulnerable to other age-related pathologies. However, recent progress in ageing research has highlighted the accumulation of senescent cells with chronological age as a probable underlying cause of pathological ageing. Cellular senescence is an essentially irreversible proliferation arrest mechanism that has important roles in development, wound healing, and preventing cancer, but it may limit tissue function and cause widespread inflammation with age. The serine\/threonine kinase mTOR (mechanistic target of rapamycin) is a regulatory nexus that is heavily implicated in both ageing and senescence. Excitingly, a growing body of research has highlighted rapamycin and other mTOR inhibitors as promising treatments for a broad spectrum of age-related pathologies, including neurodegeneration, cancer, immunosenescence, osteoporosis, rheumatoid arthritis, age-related blindness, diabetic nephropathy, muscular dystrophy, and cardiovascular disease. In this review, we assess the use of mTOR inhibitors to treat age-related pathologies, discuss possible molecular mechanisms of action where evidence is available, and consider strategies to minimize undesirable side effects. We also emphasize the urgent need for reliable, non-invasive biomarkers of senescence and biological ageing to better monitor the efficacy of any healthy ageing therapy.<\/jats:p>","DOI":"10.3390\/ijms19082325","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T03:33:48Z","timestamp":1533785628000},"page":"2325","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases"],"prefix":"10.3390","volume":"19","author":[{"given":"Hannah E.","family":"Walters","sequence":"first","affiliation":[{"name":"Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-285X","authenticated-orcid":false,"given":"Lynne S.","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Blasco","year":"2013","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature16932","article-title":"Naturally occurring p16Ink4a-positive cells shorten healthy lifespan","volume":"530","author":"Baker","year":"2016","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrm3823","article-title":"Cellular senescence: From physiology to pathology","volume":"15","author":"Serrano","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.18632\/aging.100527","article-title":"Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues","volume":"5","author":"Georgakopoulou","year":"2013","journal-title":"Aging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types","volume":"14","author":"Horvath","year":"2013","journal-title":"Genome Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cell.2013.10.019","article-title":"Programmed cell senescence during mammalian embryonic development","volume":"155","author":"Canamero","year":"2013","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","article-title":"An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA","volume":"31","author":"Demaria","year":"2014","journal-title":"Dev. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1101\/gad.227512.113","article-title":"Cell fusion induced by ERVWE1 or measles virus causes cellular senescence","volume":"27","author":"Chuprin","year":"2013","journal-title":"Genes Dev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a","volume":"88","author":"Serrano","year":"1997","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Coppe","year":"2008","journal-title":"PLoS Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","article-title":"The role of senescent cells in ageing","volume":"509","year":"2014","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/acel.12592","article-title":"Quantitative identification of senescent cells in aging and disease","volume":"16","author":"Biran","year":"2017","journal-title":"Aging Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1126\/science.1122446","article-title":"Cellular senescence in aging primates","volume":"311","author":"Herbig","year":"2006","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1101\/gad.279661.116","article-title":"Proteomic analysis reveals GIT1 as a novel mTOR complex component critical for mediating astrocyte survival","volume":"30","author":"Smithson","year":"2016","journal-title":"Genes Dev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semcdb.2014.09.011","article-title":"Growing knowledge of the mTOR signaling network","volume":"36","author":"Huang","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1083\/jcb.201610060","article-title":"Localization of mTORC2 activity inside cells","volume":"216","author":"Ebner","year":"2017","journal-title":"J. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/acel.12313","article-title":"Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins","volume":"14","author":"Schreiber","year":"2015","journal-title":"Aging Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.1199498","article-title":"The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling","volume":"332","author":"Hsu","year":"2011","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1074\/mcp.M114.045807","article-title":"Functional Proteomics Identifies Acinus L as a Direct Insulin- and Amino Acid-Dependent Mammalian Target of Rapamycin Complex 1 (mTORC1) Substrate","volume":"14","author":"Schwarz","year":"2015","journal-title":"Mol. Cell. Proteom."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1074\/mcp.M900326-MCP200","article-title":"Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response","volume":"9","author":"Bandhakavi","year":"2010","journal-title":"Mol. Cell. Proteom."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.semcdb.2014.09.014","article-title":"The ever-evolving role of mTOR in translation","volume":"36","author":"Fonseca","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.1115535","article-title":"Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients","volume":"310","author":"Kaeberlein","year":"2005","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/426620a","article-title":"Genetics: Influence of TOR kinase on lifespan in C. elegans","volume":"426","author":"Vellai","year":"2003","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4161\/auto.4989","article-title":"Autophagy is required for dietary restriction-mediated life span extension in C. elegans","volume":"3","author":"Jia","year":"2007","journal-title":"Autophagy"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1474-9726.2006.00267.x","article-title":"Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans","volume":"6","author":"Hansen","year":"2007","journal-title":"Aging Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cub.2004.03.059","article-title":"Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway","volume":"14","author":"Kapahi","year":"2004","journal-title":"Curr. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1177221","article-title":"Ribosomal protein S6 kinase 1 signaling regulates mammalian life span","volume":"326","author":"Selman","year":"2009","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.transproceed.2011.05.001","article-title":"Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: A long-term analysis of various treatment regimens","volume":"43","author":"Gyurus","year":"2011","journal-title":"Transpl. Proc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/acel.12248","article-title":"mTORC2-SGK-1 acts in two environmentally responsive pathways with opposing effects on longevity","volume":"13","author":"Mizunuma","year":"2014","journal-title":"Aging Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1083\/jcb.201610113","article-title":"Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing","volume":"216","author":"Carroll","year":"2017","journal-title":"J. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.18632\/aging.101155","article-title":"Gerosuppression by pan-mTOR inhibitors","volume":"8","author":"Leontieva","year":"2016","journal-title":"Aging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.18632\/aging.100872","article-title":"Reversal of phenotypes of cellular senescence by pan-mTOR inhibition","volume":"8","author":"Walters","year":"2016","journal-title":"Aging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm1052","article-title":"mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways","volume":"10","author":"Majumder","year":"2004","journal-title":"Nat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.4049\/jimmunol.174.12.7592","article-title":"TCR engagement increases hypoxia-inducible factor-1\u03b1 protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells","volume":"174","author":"Nakamura","year":"2005","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/acel.12122","article-title":"Reduced mammalian target of rapamycin activity facilitates mitochondrial retrograde signaling and increases life span in normal human fibroblasts","volume":"12","author":"Lerner","year":"2013","journal-title":"Aging Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1238303","DOI":"10.1126\/science.1238303","article-title":"Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state","volume":"341","author":"Santagata","year":"2013","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1093\/nar\/gks038","article-title":"Transcriptional regulation of gene expression during osmotic stress responses by the mammalian target of rapamycin","volume":"40","author":"Ortells","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.semcdb.2014.08.004","article-title":"mTORC1 signaling controls multiple steps in ribosome biogenesis","volume":"36","author":"Iadevaia","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41467-017-00322-z","article-title":"Nucleolar expansion and elevated protein translation in premature aging","volume":"8","author":"Buchwalter","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"16083","DOI":"10.1038\/ncomms16083","article-title":"Small nucleoli are a cellular hallmark of longevity","volume":"8","author":"Tiku","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gad.13.11.1422","article-title":"Regulation of 4E-BP1 phosphorylation: A novel two-step mechanism","volume":"13","author":"Gingras","year":"1999","journal-title":"Genes Dev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jcb.22145","article-title":"Rapamycin selectively reduces the association of transcripts containing complex 5\u2019 UTRs with ribosomes in C4-2B prostate cancer cells","volume":"107","author":"Opdenaker","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"Choo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cell.2011.02.014","article-title":"Activation of mTORC2 by association with the ribosome","volume":"144","author":"Zinzalla","year":"2011","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1038\/emboj.2010.271","article-title":"mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide","volume":"29","author":"Oh","year":"2010","journal-title":"EMBO J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1038\/srep18722","article-title":"Restriction of protein synthesis abolishes senescence features at cellular and organismal levels","volume":"6","author":"Takauji","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"27385","DOI":"10.1074\/jbc.M110.120295","article-title":"mTORC1 links protein quality and quantity control by sensing chaperone availability","volume":"285","author":"Qian","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.cmet.2016.05.009","article-title":"The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging","volume":"23","author":"Kennedy","year":"2016","journal-title":"Cell Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1101\/gad.519709","article-title":"Autophagy mediates the mitotic senescence transition","volume":"23","author":"Young","year":"2009","journal-title":"Genes Dev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.1009485107","article-title":"Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer\u2019s disease","volume":"107","author":"Lipinski","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.27305","article-title":"Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis","volume":"62","author":"Carames","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Fernandez, A.F., Sebti, S., Wei, Y., Zou, Z., Shi, M., McMillan, K.L., He, C., Ting, T., Liu, Y., and Chiang, W.C. (2018). Disruption of the beclin 1-BCL2 autophagy regulatory complex promotes longevity in mice. Nature.","DOI":"10.1038\/s41586-018-0270-4"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Sung, J.Y., Lee, K.Y., Kim, J.R., and Choi, H.C. (2017). Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53\/p21\/p16. Exp. Gerontol.","DOI":"10.1016\/j.exger.2017.08.001"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2011.07.030","article-title":"Autophagy and aging","volume":"146","author":"Rubinsztein","year":"2011","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Puleston, D.J., Zhang, H., Powell, T.J., Lipina, E., Sims, S., Panse, I., Watson, A.S., Cerundolo, V., Townsend, A.R., and Klenerman, P. (2014). Autophagy is a critical regulator of memory CD8+ T cell formation. eLife, 3.","DOI":"10.7554\/eLife.03706"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41419-017-0085-5","article-title":"Sirt6 overexpression suppresses senescence and apoptosis of nucleus pulposus cells by inducing autophagy in a model of intervertebral disc degeneration","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41419-018-0383-6","article-title":"Simultaneous induction and blockade of autophagy by a single agent","volume":"9","author":"Kucharewicz","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Passos, J.F., Saretzki, G., Ahmed, S., Nelson, G., Richter, T., Peters, H., Wappler, I., Birket, M.J., Harold, G., and Schaeuble, K. (2007). Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol., 5.","DOI":"10.1371\/journal.pbio.0050110"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ebiom.2017.03.020","article-title":"Mitochondria in Cell Senescence: Is Mitophagy the Weakest Link?","volume":"21","author":"Korolchuk","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15252\/embj.201592862","article-title":"Mitochondria are required for pro-ageing features of the senescent phenotype","volume":"35","author":"Marques","year":"2016","journal-title":"EMBO J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/msb.2010.5","article-title":"Feedback between p21 and reactive oxygen production is necessary for cell senescence","volume":"6","author":"Passos","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1242\/jcs.059246","article-title":"Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1","volume":"123 Pt 6","author":"Mai","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"E3388","DOI":"10.1073\/pnas.1722452115","article-title":"S-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagy","volume":"115","author":"Rizza","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","article-title":"mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation","volume":"18","author":"Morita","year":"2013","journal-title":"Cell Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nature06322","article-title":"mTOR controls mitochondrial oxidative function through a YY1-PGC-1\u03b1 transcriptional complex","volume":"450","author":"Cunningham","year":"2007","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.celrep.2013.12.040","article-title":"TOR complex 2-Ypk1 signaling maintains sphingolipid homeostasis by sensing and regulating ROS accumulation","volume":"6","author":"Niles","year":"2014","journal-title":"Cell Rep."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Cai, W., and Andres, D.A. (2014). mTORC2 is required for rit-mediated oxidative stress resistance. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0115602"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"20534","DOI":"10.1074\/jbc.M611782200","article-title":"Hypoxia-inducible factor 1\u03b1 is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif","volume":"282","author":"Land","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.cell.2013.11.037","article-title":"Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging","volume":"155","author":"Gomes","year":"2013","journal-title":"Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4161\/cc.27973","article-title":"M(o)TOR of pseudo-hypoxic state in aging: Rapamycin to the rescue","volume":"13","author":"Leontieva","year":"2014","journal-title":"Cell Cycle"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ncb3195","article-title":"MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation","volume":"17","author":"Laberge","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ncb3225","article-title":"mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype","volume":"17","author":"Herranz","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10522-015-9610-z","article-title":"Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2","volume":"17","author":"Alimbetov","year":"2016","journal-title":"Biogerontology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1182\/blood-2010-09-310888","article-title":"Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells","volume":"117","author":"Weichhart","year":"2011","journal-title":"Blood"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/j.1600-6143.2009.02832.x","article-title":"The multifunctional role of mTOR in innate immunity: Implications for transplant immunity","volume":"9","author":"Saemann","year":"2009","journal-title":"Am. J. Transpl."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"427","DOI":"10.18632\/oncotarget.2813","article-title":"DNA damage-induced S and G2\/M cell cycle arrest requires mTORC2-dependent regulation of Chk1","volume":"6","author":"Selvarajah","year":"2015","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","article-title":"The regulation of AMPK \u03b21, TSC2, and PTEN expression by p53: Stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways","volume":"67","author":"Feng","year":"2007","journal-title":"Cancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/sj.emboj.7601900","article-title":"Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53","volume":"26","author":"Lee","year":"2007","journal-title":"EMBO J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-61779-430-8_4","article-title":"mTOR activity under hypoxia","volume":"821","author":"Vadysirisack","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/emboj.2010.166","article-title":"S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response","volume":"29","author":"Lai","year":"2010","journal-title":"EMBO J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/bies.950170606","article-title":"Tumour suppressors, kinases and clamps: How p53 regulates the cell cycle in response to DNA damage","volume":"17","author":"Cox","year":"1995","journal-title":"Bioessays"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0065-230X(01)82002-9","article-title":"p53-dependent apoptosis pathways","volume":"82","author":"Shen","year":"2001","journal-title":"Adv. Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/onc.2011.394","article-title":"AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: Implications for targeting mTOR during malignancy","volume":"31","author":"Astle","year":"2012","journal-title":"Oncogene"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41556-017-0033-8","article-title":"The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168","volume":"20","author":"Xie","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0092-8674(05)80095-9","article-title":"SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene","volume":"75","author":"Yokoyama","year":"1993","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","article-title":"SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth","volume":"8","author":"Porstmann","year":"2008","journal-title":"Cell Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","article-title":"mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway","volume":"146","author":"Peterson","year":"2011","journal-title":"Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1194\/jlr.M021485","article-title":"Major involvement of mTOR in the PPAR\u03b3-induced stimulation of adipose tissue lipid uptake and fat accretion","volume":"53","author":"Blanchard","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR\u03b1 in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nature09584","article-title":"mTORC1 controls fasting-induced ketogenesis and its modulation by ageing","volume":"468","author":"Sengupta","year":"2010","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1172\/JCI29528","article-title":"Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2","volume":"117","author":"Petroulakis","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"17075","DOI":"10.1038\/cddiscovery.2017.75","article-title":"A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence","volume":"3","author":"Flor","year":"2017","journal-title":"Cell Death Discov."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7164\/antibiotics.28.721","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle","volume":"28","author":"Vezina","year":"1975","journal-title":"J. Antibiot."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/00007890-200010270-00021","article-title":"Conversion to rapamycin immunosuppression in renal transplant recipients: Report of an initial experience","volume":"70","author":"Dominguez","year":"2000","journal-title":"Transplantation"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/msb.2010.108","article-title":"A comprehensive map of the mTOR signaling network","volume":"6","author":"Caron","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbagen.2009.06.007","article-title":"The TOR pathway comes of age","volume":"1790","author":"Stanfel","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"mTOR kinase structure, mechanism and regulation","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.0903534","article-title":"Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1","volume":"186","author":"Joung","year":"2011","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2011.06.004","article-title":"Function of erbB receptors and DNA-PKcs on phosphorylation of cytoplasmic and nuclear Akt at S473 induced by erbB1 ligand and ionizing radiation","volume":"101","author":"Toulany","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/onc.2016.363","article-title":"mTORC1 and mTORC2 in cancer and the tumor microenvironment","volume":"36","author":"Kim","year":"2017","journal-title":"Oncogene"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","article-title":"AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity","volume":"70","author":"Chresta","year":"2010","journal-title":"Cancer Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity","volume":"7","author":"Maira","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nsmb.2076","article-title":"A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations","volume":"18","author":"Toledo","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.4161\/cc.8.12.8606","article-title":"Rapamycin decelerates cellular senescence","volume":"8","author":"Demidenko","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Mannick, J.B., Morris, M., Hockey, H.-U.P., Roma, G., Beibel, M., Kulmatycki, K., Watkins, M., Shavlakadze, T., Zhou, W., and Quinn, D. (2018). TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci. Transl. Med., 10.","DOI":"10.1126\/scitranslmed.aaq1564"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/bjc.2012.368","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma","volume":"107","author":"Naing","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/1535-7163.MCT-10-1099","article-title":"Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: Distinct from rapamycin","volume":"10","author":"Bhagwat","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/jcb.25950","article-title":"Therapeutic Potential of Targeting PI3K\/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress","volume":"119","author":"Bahrami","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Benavides-Serrato, A., Lee, J., Holmes, B., Landon, K.A., Bashir, T., Jung, M.E., Lichtenstein, A., and Gera, J. (2017). Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176599"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10637-015-0218-6","article-title":"A phase 1 study of the sachet formulation of the oral dual PI3K\/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors","volume":"33","author":"Bendell","year":"2015","journal-title":"Investig. New Drugs"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/bju.13415","article-title":"Phase II study of dual phosphoinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma","volume":"118","author":"Seront","year":"2016","journal-title":"BJU Int."},{"key":"ref_118","first-page":"713","article-title":"A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours","volume":"36","author":"Fazio","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2006.03.029","article-title":"A dual PI3 kinase\/mTOR inhibitor reveals emergent efficacy in glioma","volume":"9","author":"Fan","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cellsig.2016.11.011","article-title":"Bromodomain-containing protein 2 induces insulin resistance via the mTOR\/Akt signaling pathway and an inflammatory response in adipose tissue","volume":"30","author":"Sun","year":"2017","journal-title":"Cell. Signal."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diabetes.52.3.588","article-title":"Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo","volume":"52","author":"Ring","year":"2003","journal-title":"Diabetes"},{"key":"ref_122","first-page":"2755","article-title":"LMO3 promotes gastric cancer cell invasion and proliferation through Akt-mTOR and Akt-GSK3\u03b2 signaling","volume":"41","author":"Qiu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1038\/srep05519","article-title":"An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E\u2212\/\u2212 mice","volume":"4","author":"Peng","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4161\/auto.28363","article-title":"Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells","volume":"10","author":"Ge","year":"2014","journal-title":"Autophagy"},{"key":"ref_125","unstructured":"(2018, June 03). Selleckchem.com. Available online: http:\/\/www.selleckchem.com\/."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1474-9726.2012.00832.x","article-title":"Rapamycin slows aging in mice","volume":"11","author":"Wilkinson","year":"2002","journal-title":"Aging Cell"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.maturitas.2015.05.004","article-title":"Immunosenescence: Implications for response to infection and vaccination in older people","volume":"82","author":"Pera","year":"2015","journal-title":"Maturitas"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/acel.12380","article-title":"Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice","volume":"14","author":"Hurez","year":"2015","journal-title":"Aging Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2147\/NDT.S91248","article-title":"Profile of everolimus in the treatment of tuberous sclerosis complex: An evidence-based review of its place in therapy","volume":"12","author":"Capal","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1474-9726.2011.00791.x","article-title":"Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1\u03b2 and enhancing NMDA signaling","volume":"11","author":"Majumder","year":"2012","journal-title":"Aging Cell"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nn.3362","article-title":"mTORC2: Actin on your memory","volume":"16","author":"Josselyn","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1083\/jcb.201205030","article-title":"Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology","volume":"201","author":"Thomanetz","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.transproceed.2009.08.050","article-title":"Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: Pilot study shows significant cognitive and affective improvement","volume":"41","author":"Lang","year":"2009","journal-title":"Transpl. Proc."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9440(10)63687-5","article-title":"Up-regulation of phosphorylated\/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer\u2019s disease","volume":"163","author":"An","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1111\/j.1582-4934.2008.00509.x","article-title":"mTOR-dependent signalling in Alzheimer\u2019s disease","volume":"12","author":"Pei","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2741\/s310","article-title":"The role of mTOR signaling in Alzheimer disease","volume":"4","author":"Oddo","year":"2012","journal-title":"Front. Biosci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-\u03b2, and Tau: Effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Spilman, P., Podlutskaya, N., Hart, M.J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., and Galvan, V. (2010). Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of Alzheimer\u2019s disease. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009979"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Majumder, S., Richardson, A., Strong, R., and Oddo, S. (2011). Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025416"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","article-title":"Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer\u2019s disease","volume":"33","author":"Lin","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1523\/JNEUROSCI.0777-14.2014","article-title":"Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer\u2019s disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature","volume":"34","author":"Caccamo","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.tig.2008.10.002","article-title":"Autophagy and aging: Keeping that old broom working","volume":"24","author":"Cuervo","year":"2008","journal-title":"Trends Genet."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","article-title":"Inhibition of glycogen synthase kinase-3 ameliorates beta-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: In vivo and in vitro studies","volume":"288","author":"Avrahami","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2014.12.019","article-title":"Reinstating aberrant mTORC1 activity in Huntington\u2019s disease mice improves disease phenotypes","volume":"85","author":"Lee","year":"2015","journal-title":"Neuron"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbadis.2009.08.013","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"1802","author":"Winklhofer","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.cellsig.2014.04.009","article-title":"Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson\u2019s disease","volume":"26","author":"Xu","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/toxsci\/kfu211","article-title":"Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1\/eIF4E pathways, leading to neuronal apoptosis","volume":"143","author":"Zhou","year":"2015","journal-title":"Toxicol. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"ra36","DOI":"10.1126\/scisignal.2000308","article-title":"Inhibition of mTOR signaling in Parkinson\u2019s disease prevents L-DOPA-induced dyskinesia","volume":"2","author":"Santini","year":"2009","journal-title":"Sci. Signal."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-016-8417-7","article-title":"mTOR Signaling in Parkinson\u2019s Disease","volume":"19","author":"Lan","year":"2017","journal-title":"Neuromol. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-017-0154-3","article-title":"Therapeutic potential of autophagy-enhancing agents in Parkinson\u2019s disease","volume":"12","author":"Moors","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ajpath.2012.04.018","article-title":"Prevention of age-related macular degeneration-like retinopathy by rapamycin in rats","volume":"181","author":"Kolosova","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1167\/iovs.13-11650","article-title":"Treatment of geographic atrophy with subconjunctival sirolimus: Results of a phase I\/II clinical trial","volume":"54","author":"Wong","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nbt.4114","article-title":"Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration","volume":"36","author":"Fynes","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jor.23409","article-title":"mTOR signaling plays a critical role in the defects observed in muscle-derived stem\/progenitor cells isolated from a murine model of accelerated aging","volume":"35","author":"Takayama","year":"2017","journal-title":"J. Orthop. Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"89ra58","DOI":"10.1126\/scitranslmed.3002346","article-title":"Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells","volume":"3","author":"Cao","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_157","unstructured":"(2018, June 03). Progeria Research Foundation (PRF). Available online: https:\/\/www.progeriaresearch.org\/clinical-trials\/."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"40513","DOI":"10.1074\/jbc.M112.404541","article-title":"Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A\/C (LMNA) gene mutation","volume":"287","author":"Choi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"144ra103","DOI":"10.1126\/scitranslmed.3003802","article-title":"Rapamycin reverses elevated mTORC1 signaling in lamin A\/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival","volume":"4","author":"Ramos","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cell.2013.02.015","article-title":"When lamins go bad: Nuclear structure and disease","volume":"152","author":"Schreiber","year":"2013","journal-title":"Cell"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/mco.2016.1015","article-title":"Muscle wasting associated with the long-term use of mTOR inhibitors","volume":"5","author":"Gyawali","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11357-017-9972-z","article-title":"A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs","volume":"39","author":"Urfer","year":"2017","journal-title":"Geroscience"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Hazeldine, J., Naumann, D.N., Toman, E., Davies, D., Bishop, J.R.B., Su, Z., Hampson, P., Dinsdale, R.J., Crombie, N., and Duggal, N.A. (2017). Prehospital immune responses and development of multiple organ dysfunction syndrome following traumatic injury: A prospective cohort study. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002338"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2017.01.006","article-title":"Frailty and sarcopenia: The potential role of an aged immune system","volume":"36","author":"Wilson","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/emboj.2009.127","article-title":"Transcription factor C\/EBP\u03b2 isoform ratio regulates osteoclastogenesis through MafB","volume":"28","author":"Smink","year":"2009","journal-title":"EMBO J."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00109-009-0567-8","article-title":"Rapamycin and the transcription factor C\/EBP\u03b2 as a switch in osteoclast differentiation: Implications for lytic bone diseases","volume":"88","author":"Smink","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.cdd.4401285","article-title":"M-CSF, TNF\u03b1 and RANK ligand promote osteoclast survival by signaling through mTOR\/S6 kinase","volume":"10","author":"Glantschnig","year":"2003","journal-title":"Cell Death Differ."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bone.2004.07.013","article-title":"Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts","volume":"35","author":"Kneissel","year":"2004","journal-title":"Bone"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.27504","article-title":"Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis","volume":"62","author":"Cejka","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2007.078808","article-title":"Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: A 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept study","volume":"67","author":"Bruyn","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/annrheumdis-2011-200557","article-title":"Autophagy activation by rapamycin reduces severity of experimental osteoarthritis","volume":"71","author":"Carames","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40268-015-0082-z","article-title":"mTOR: A potential therapeutic target in osteoarthritis?","volume":"15","author":"Pal","year":"2015","journal-title":"Drugs R&D"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00125-017-4269-4","article-title":"Diabetes, bone and glucose-lowering agents: Basic biology","volume":"60","year":"2017","journal-title":"Diabetologia"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00223-016-0149-z","article-title":"Changes in the Fracture Resistance of Bone with the Progression of Type 2 Diabetes in the ZDSD Rat","volume":"99","author":"Creecy","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000226225","article-title":"Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE\/p38 MAPK","volume":"46","author":"Tanikawa","year":"2009","journal-title":"J. Vasc. Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2016.05.004","article-title":"Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise","volume":"23","author":"Mera","year":"2016","journal-title":"Cell Metab."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mce.2017.01.049","article-title":"Corrigendum to \u201cMetformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms\u201d [Mol. Cell. Endocrinol. 440 15 January 2017 57\u201368]","volume":"443","author":"Chen","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"4847812","DOI":"10.1155\/2016\/4847812","article-title":"Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE\/NFkappaB Pathway Suppression","volume":"2016","author":"Zhou","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000057979.36322.88","article-title":"Rapamycin attenuates load-induced cardiac hypertrophy in mice","volume":"107","author":"Shioi","year":"2003","journal-title":"Circulation"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/01.CIR.0000130641.08705.45","article-title":"Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload","volume":"109","author":"McMullen","year":"2004","journal-title":"Circulation"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jvs.2004.05.020","article-title":"Rapamycin suppresses experimental aortic aneurysm growth","volume":"40","author":"Lawrence","year":"2004","journal-title":"J. Vasc. Surg."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/acel.12109","article-title":"Late-life rapamycin treatment reverses age-related heart dysfunction","volume":"12","author":"Flynn","year":"2013","journal-title":"Aging Cell"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCRESAHA.109.208272","article-title":"Rad as a novel regulator of excitation-contraction coupling and \u03b2-adrenergic signaling in heart","volume":"106","author":"Wang","year":"2010","journal-title":"Circ. Res."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/acel.12203","article-title":"Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart","volume":"13","author":"Dai","year":"2014","journal-title":"Aging Cell"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.yjmcc.2006.04.014","article-title":"Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes","volume":"41","author":"Khan","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.yjmcc.2012.09.007","article-title":"Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway","volume":"53","author":"Das","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00395-015-0486-5","article-title":"Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling","volume":"110","author":"Das","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1074\/jbc.M113.521062","article-title":"Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: Potential role of attenuated oxidative stress and altered contractile protein expression","volume":"289","author":"Das","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ndt\/gfp129","article-title":"Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)","volume":"24","author":"Zafar","year":"2009","journal-title":"Nephrol Dial. Transpl."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_195","first-page":"133","article-title":"Rapamycin reduces kidney volume and delays the loss of renal function in a patient with autosomal-dominant polycystic kidney disease","volume":"2","author":"Peces","year":"2009","journal-title":"NDT Plus"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1681\/ASN.2007050626","article-title":"Sirolimus reduces polycystic liver volume in ADPKD patients","volume":"19","author":"Qian","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.transproceed.2013.10.040","article-title":"Sirolimus for treatment of autosomal-dominant polycystic kidney disease: A meta-analysis of randomized controlled trials","volume":"46","author":"Liu","year":"2014","journal-title":"Transpl. Proc."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/nep.12211","article-title":"Treatments to slow progression of autosomal dominant polycystic kidney disease: Systematic review and meta-analysis of randomized trials","volume":"19","author":"Myint","year":"2014","journal-title":"Nephrology"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Bolignano, D., Palmer, S.C., Ruospo, M., Zoccali, C., Craig, J.C., and Strippoli, G.F. (2015). Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database Syst. Rev., CD010294.","DOI":"10.1002\/14651858.CD010294.pub2"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/ndt\/gfs519","article-title":"mTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): The question remains open","volume":"28","author":"Jardine","year":"2013","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJMcp011773","article-title":"Clinical practice. Nephropathy in patients with type 2 diabetes","volume":"346","author":"Remuzzi","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1172\/JCI44771","article-title":"mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice","volume":"121","author":"Inoki","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1681\/ASN.2005050549","article-title":"Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats","volume":"17","author":"Lloberas","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000106782","article-title":"Rapamycin prevents early steps of the development of diabetic nephropathy in rats","volume":"27","author":"Yang","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbrc.2005.12.012","article-title":"Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice","volume":"340","author":"Sakaguchi","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bbrc.2009.04.136","article-title":"The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential","volume":"384","author":"Mori","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11596-011-0473-5","article-title":"Everolimus vs. rapamycin for treating diabetic nephropathy in diabetic mouse model","volume":"31","author":"Cheng","year":"2011","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Kenerson, H.L., Subramanian, S., McIntyre, R., Kazami, M., and Yeung, R.S. (2015). Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117000"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","article-title":"mTORC2 Promotes Tumorigenesis via Lipid Synthesis","volume":"32","author":"Guri","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/2159-8290.CD-13-0929","article-title":"A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity","volume":"4","author":"Grabiner","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.1073\/pnas.211053698","article-title":"Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging","volume":"98","author":"Krtolica","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/0008-5472.CAN-06-3452","article-title":"Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion","volume":"67","author":"Liu","year":"2007","journal-title":"Cancer Res."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jcp.25443","article-title":"Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer","volume":"232","author":"Alayev","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"e1281","DOI":"10.1038\/cddis.2014.242","article-title":"Rapamycin-enhanced mitomycin C-induced apoptotic death is mediated through the S6K1-Bad-Bak pathway in peritoneal carcinomatosis","volume":"5","author":"Song","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1185\/03007995.2013.846253","article-title":"Everolimus: A new hope for patients with breast cancer","volume":"30","author":"Sendur","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.radonc.2015.07.039","article-title":"A phase I-II study on the combination of rapamycin and short course radiotherapy in rectal cancer","volume":"116","author":"Buijsen","year":"2015","journal-title":"Radiother. Oncol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ajh.24671","article-title":"Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma","volume":"92","author":"Bennani","year":"2017","journal-title":"Am. J. Hematol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40164-018-0103-z","article-title":"Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma","volume":"7","author":"Johnston","year":"2018","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-13-0353","article-title":"Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib","volume":"4","author":"Wagle","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.celrep.2015.07.016","article-title":"A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation","volume":"12","author":"Yang","year":"2015","journal-title":"Cell Rep."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00109-011-0834-3","article-title":"Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity","volume":"90","author":"Yang","year":"2012","journal-title":"J. Mol. Med."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/db07-0922","article-title":"mTOR inhibition by rapamycin prevents \u03b2-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes","volume":"57","author":"Fraenkel","year":"2008","journal-title":"Diabetes"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/acel.12405","article-title":"Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system","volume":"15","author":"Neuman","year":"2016","journal-title":"Aging Cell"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Weiss, R., Fernandez, E., Liu, Y., Strong, R., and Salmon, A.B. (2018). Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging.","DOI":"10.18632\/aging.101401"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"15691","DOI":"10.1038\/ncomms15691","article-title":"Cellular senescence drives age-dependent hepatic steatosis","volume":"8","author":"Ogrodnik","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm.4324","article-title":"Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment","volume":"23","author":"Jeon","year":"2017","journal-title":"Nat. Med."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"407","DOI":"10.18632\/aging.100318","article-title":"Reversing the aging stromal phenotype prevents carcinoma initiation","volume":"3","author":"Lewis","year":"2011","journal-title":"Aging"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2325\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:17:20Z","timestamp":1760195840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,8]]},"references-count":228,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["ijms19082325"],"URL":"https:\/\/doi.org\/10.3390\/ijms19082325","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201806.0056.v1","asserted-by":"object"}]},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,8]]}}}